Vaccine-Med's Factsheet February 28, 2026

Vaccine-Med avatar

Vaccine-Med
🇬🇧 Stock Smart Portfolio.
292 copiers.
FEBRUARY
+14.8%
YEAR TO DATE
+39.93%
1 YEAR
+66.21%
5 YEARS
-35.64%
ANNUALIZED RETURN
-7.11%
TRACK RECORD
5.4 years

About Vaccine-Med

Vaccines have saved millions of lives for decades and protect against infectious diseases. With the recent Covid-19 pandemic, vaccine development became one of the hottest topics globally, as efforts to immunize the population from this virus turned into a priority for all.

Several infectious diseases have efficient prophylactic (preventive) vaccines available. In the future, new infections will appear, and new vaccines will have to be developed. The global vaccine market enjoys high entry barriers and benefits from substantial funding from government and humanitarian organisations for Research & Development.

Vaccine-Med Smart Portfolio allocates in stocks, based on eToro's asset universe, of vaccines manufacturers, among Pharmaceuticals and Biotechnology companies from all parts of the world, that have ongoing studies in several phases of existing and new vaccines for diseases that affect humans.

The minimum investment amount for this portfolio is $500.

    Smart Portfolio Stats

    Type

    Smart Portfolio

    Copiers

    292

    Assets Under Copy

    $300K-$1M

    Risk Score

    5

    Trades

    Most Traded

    Dynavax

    Win Rate

    Trade Stats

    Average Profit: +32.9%

    Average Duration: 1316 days

    Long Positions: 100%

    Average Leverage: 1x

    Trades during February 2026

    InstrumentProfitDurationClosedOpen RateClose RateSince Closed
    DVAX
    BUY DVAX
    +18.05%4 years
    20 days ago
    $13.13$15.50%
    DVAX
    BUY DVAX
    +47.76%3 years
    20 days ago
    $10.49$15.50%

    Drawdowns

      Worst Drawdowns

      Depth
      Start
      End
      Total months
      -72.47%
      Sep 2021-54
      -14.81%
      Feb 2021Apr 20212
      -13.8%
      May 2021Aug 20213
      -2.68%
      Dec 2020Jan 20211

      Performance Metrics

      Score 2.5/10

      Beta

      1.01
      1.01
      0
      0.8
      1.2
      0
      2

      Sharpe Ratio

      -0.13
      -0.13
      -1
      0.5
      1
      1.5
      1.5

      Sortino Ratio

      -0.2
      -0.2
      -1
      1
      2
      3
      3

      Jensen's Alpha

      -15.9
      -15.9
      -16
      0
      2
      4.5
      4.5

      Omega Ratio

      0.66
      0.66
      0
      1
      1.5
      2.5
      2.5

      Treynor Ratio

      -0.38
      -0.38
      -1
      0.75
      1.25
      2
      2

      Information Ratio

      -0.54
      -0.54
      -1
      0.3
      0.6
      1
      1

      Calmar Ratio

      -0.1
      -0.1
      -1
      0.3
      0.6
      1
      1

      Diversification

      Sectors Breakdown

      • Sector
      • Total
      • 🧬 Health Technology
        86.02%
      • 💵 Cash
        7.43%
      • 🏥 Health Services
        7.06%

      Exchanges Breakdown

      • Exchange
      • Total
      • 🇺🇸 Nasdaq
        67.58%
      • 🇺🇸 NYSE
        21.64%
      • 🇫🇷 Euronext Paris
        3.87%

      Countries Breakdown

      • Country
      • Total
      • 🇺🇸 United States
        77.51%
      • 🇫🇷 France
        6.95%
      • 🇩🇪 Germany
        5.13%
      • 🇬🇧 United Kingdom
        3.49%

      Dividends

      Dividend Yield

      0.79%

      7 out of 18 instruments pay dividend.

      0 dividend payments in the next 30 days.

      Highest Dividend: $PFE (6.5%)

      Dividend Yield Breakdown

      Instrument
      Portfolio Yield
      Company Yield
      Per Share
      PFE
      PFE
      0.24%
      6.5%
      $1.66
      MRK
      MRK
      0.14%
      2.79%
      $3.04
      SNY
      SNY
      0.11%
      3.44%
      $1.48
      JNJ
      JNJ
      0.1%
      2.11%
      $4.81
      ABT
      ABT
      0.08%
      2.15%
      $2.16
      ZTS
      ZTS
      0.07%
      1.65%
      $1.67
      AZN
      AZN
      0.06%
      1.59%
      $1.42

      Next Dividends

      Stock
      Type
      Date
      Pay Per Share

      Portfolio Holdings

      (As of February 28, 2026)

      Monthly Returns

      Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk. Past performance is not an indication of future results